Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Prednisolone × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Follicular 4 Lymphoma 4 Burkitt Lymphoma 4 Ovarian Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hodgkin Disease 2 Endometrial Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Heart Failure 1 Esophageal Stenosis 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

rozanolixizumab 7 zilucoplan 6 efgartigimod alfa 5 telitacicept 4 ravulizumab 4 fludarabine 4 Cyclophosphamide 4 Prednisone 3 inebilizumab 2 Pyridostigmine Bromide 2 tofacitinib 1 thymoglobulin 1 remibrutinib 1 prednylidene 1 iptacopan 1 eculizumab 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 blinatumomab 1 Walk Test 1 Tacrolimus 1 Sugammadex 1 Steroids 1 Robotic Surgical Procedures 1 Rituximab 1 Psychodrama 1 Prednisolone 1 Peripheral Blood Stem Cell Transplantation 1 Oxaloacetic Acid 1 Neostigmine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡